Mares make up a significant portion of the performance horse population across disciplines, and the question of whether hormonal cycles influence soft tissue vulnerability is a legitimate one with a more substantive answer than the topic typically receives. The connection between reproductive hormones and connective tissue laxity is well-established in human medicine. The equine picture is less thoroughly researched but carries enough evidence to be worth understanding for anyone managing performance mares through demanding seasons.
What the Research Shows in Other Species
The clearest evidence for hormonal influence on soft tissue comes from human sports medicine, where the relationship between estrogen and ligament laxity has been studied extensively. Estrogen receptors are present in ligament tissue. Elevated estrogen levels, which occur during the follicular phase of the menstrual cycle, have been associated with increased ligament laxity and higher rates of anterior cruciate ligament injury in female athletes. The mechanism involves estrogen's influence on collagen synthesis and the structural properties of the extracellular matrix within connective tissue.
Relaxin, a hormone produced during pregnancy and to varying degrees during the reproductive cycle, has a direct effect on connective tissue compliance. It modulates collagen cross-linking and reduces the stiffness of ligament tissue, which is functionally important during pregnancy but represents increased soft tissue vulnerability in an athletic context.
These mechanisms are not species-specific in principle. Horses produce estrogen and relaxin, and the presence of hormone receptors in equine connective tissue has been documented. Whether the magnitude of effect is clinically significant in the context of equine athletic performance is less definitively established, but the biological plausibility is real.
What Owners and Trainers Report
Anecdotal observation among experienced mare managers is consistent enough to warrant attention. Trainers and riders who manage mares through active estrus frequently report changes in movement quality, apparent discomfort, reduced willingness, and altered muscle tone during peak hormonal periods. Some mares that are difficult to manage behaviorally during estrus also show subtle changes in the way they move and how they respond to collection, lateral demands, or jumping efforts.
Whether these observations reflect genuine soft tissue laxity, musculoskeletal discomfort from reproductive organ involvement, or behavioral expression of hormonal state is difficult to separate in a clinical setting. The likely answer is that multiple mechanisms contribute simultaneously, which is consistent with the complexity of hormonal influence on the whole body rather than any single system.
Practical Implications for Performance Mares
The practical question for owners and trainers managing performance mares is whether cycle timing should influence training intensity or monitoring practices. A definitive evidence-based protocol does not exist for horses the way it does in some human sports contexts. But a few considerations are reasonable given what is known.
Mares that show consistent behavioral or movement changes tied to their cycle warrant closer monitoring of soft tissue during those periods. Heat and swelling patterns in the lower limbs, subtle changes in gait symmetry, and any reduction in willingness under demanding work that appears cyclically should be noted and tracked rather than attributed entirely to attitude.
For mares with prior soft tissue injury history, periods of known hormonal influence represent an additional variable that experienced managers account for by moderating peak loading demands during those windows. This is not an evidence-based protocol so much as a conservative response to the biological plausibility of increased soft tissue vulnerability during estrus.
Hormonal management through veterinary-prescribed suppression is used in some performance mare programs to manage behavioral and physical cyclicity during competition season. This is a veterinary decision with welfare, regulatory, and health considerations that belong in that conversation. From a soft tissue perspective, the potential removal of a cyclical variable in soft tissue laxity is one consideration among several that bear on that decision.
Monitoring Is the Most Practical Response
Without a clear protocol for managing cyclic hormonal influence on soft tissue, consistent monitoring is the most actionable response for most performance mare owners. Tracking when in her cycle a mare tends to show behavioral or movement changes, monitoring her legs more closely during those periods, and adjusting peak training demands conservatively when she is in active estrus are practical steps that do not require definitive evidence to be reasonable.
Mares that compete in disciplines where peak soft tissue load is high, including jumping, polo, and high-speed work, during periods of known estrus may be exposed to the highest-risk combination of external mechanical demand and potential internal connective tissue variability. Awareness of that overlap is part of informed mare management.
Supporting Soft Tissue Consistently
Regardless of where a mare is in her cycle, the biological processes that support tendon and ligament health, including collagen synthesis, fiber organization, and extracellular matrix maintenance, are ongoing. Consistent nutritional support for those processes does not need to be adjusted based on cycle phase. It should be maintained throughout the training and competition season as a baseline from which the mare's soft tissue can manage whatever additional variables her hormonal cycle introduces.
Tendonall is formulated to support tendon and ligament biology and is used in management programs for performance mares as part of a sustained soft tissue strategy throughout the competition season.
The question of whether hormones affect soft tissue health in mares does not have a single definitive answer for the equine context. What it has is biological plausibility, consistent anecdotal support, and enough crossover from human sports medicine to take seriously as a management consideration. For owners and trainers responsible for performance mares through demanding seasons, that is enough to warrant attention and informed monitoring even without a complete evidence base.
Do Hormones Affect Soft Tissue Health in Mares? What Owners and Trainers Should Know
Mares make up a significant portion of the performance horse population across disciplines, and the question of whether hormonal cycles influence soft tissue vulnerability is a legitimate one with a more substantive answer than the topic typically receives. The connection between reproductive hormones and connective tissue laxity is well-established in human medicine. The equine picture is less thoroughly researched but carries enough evidence to be worth understanding for anyone managing performance mares through demanding seasons.
What the Research Shows in Other Species
The clearest evidence for hormonal influence on soft tissue comes from human sports medicine, where the relationship between estrogen and ligament laxity has been studied extensively. Estrogen receptors are present in ligament tissue. Elevated estrogen levels, which occur during the follicular phase of the menstrual cycle, have been associated with increased ligament laxity and higher rates of anterior cruciate ligament injury in female athletes. The mechanism involves estrogen's influence on collagen synthesis and the structural properties of the extracellular matrix within connective tissue.
Relaxin, a hormone produced during pregnancy and to varying degrees during the reproductive cycle, has a direct effect on connective tissue compliance. It modulates collagen cross-linking and reduces the stiffness of ligament tissue, which is functionally important during pregnancy but represents increased soft tissue vulnerability in an athletic context.
These mechanisms are not species-specific in principle. Horses produce estrogen and relaxin, and the presence of hormone receptors in equine connective tissue has been documented. Whether the magnitude of effect is clinically significant in the context of equine athletic performance is less definitively established, but the biological plausibility is real.
What Owners and Trainers Report
Anecdotal observation among experienced mare managers is consistent enough to warrant attention. Trainers and riders who manage mares through active estrus frequently report changes in movement quality, apparent discomfort, reduced willingness, and altered muscle tone during peak hormonal periods. Some mares that are difficult to manage behaviorally during estrus also show subtle changes in the way they move and how they respond to collection, lateral demands, or jumping efforts.
Whether these observations reflect genuine soft tissue laxity, musculoskeletal discomfort from reproductive organ involvement, or behavioral expression of hormonal state is difficult to separate in a clinical setting. The likely answer is that multiple mechanisms contribute simultaneously, which is consistent with the complexity of hormonal influence on the whole body rather than any single system.
Practical Implications for Performance Mares
The practical question for owners and trainers managing performance mares is whether cycle timing should influence training intensity or monitoring practices. A definitive evidence-based protocol does not exist for horses the way it does in some human sports contexts. But a few considerations are reasonable given what is known.
Mares that show consistent behavioral or movement changes tied to their cycle warrant closer monitoring of soft tissue during those periods. Heat and swelling patterns in the lower limbs, subtle changes in gait symmetry, and any reduction in willingness under demanding work that appears cyclically should be noted and tracked rather than attributed entirely to attitude.
For mares with prior soft tissue injury history, periods of known hormonal influence represent an additional variable that experienced managers account for by moderating peak loading demands during those windows. This is not an evidence-based protocol so much as a conservative response to the biological plausibility of increased soft tissue vulnerability during estrus.
Hormonal management through veterinary-prescribed suppression is used in some performance mare programs to manage behavioral and physical cyclicity during competition season. This is a veterinary decision with welfare, regulatory, and health considerations that belong in that conversation. From a soft tissue perspective, the potential removal of a cyclical variable in soft tissue laxity is one consideration among several that bear on that decision.
Monitoring Is the Most Practical Response
Without a clear protocol for managing cyclic hormonal influence on soft tissue, consistent monitoring is the most actionable response for most performance mare owners. Tracking when in her cycle a mare tends to show behavioral or movement changes, monitoring her legs more closely during those periods, and adjusting peak training demands conservatively when she is in active estrus are practical steps that do not require definitive evidence to be reasonable.
Mares that compete in disciplines where peak soft tissue load is high, including jumping, polo, and high-speed work, during periods of known estrus may be exposed to the highest-risk combination of external mechanical demand and potential internal connective tissue variability. Awareness of that overlap is part of informed mare management.
Supporting Soft Tissue Consistently
Regardless of where a mare is in her cycle, the biological processes that support tendon and ligament health, including collagen synthesis, fiber organization, and extracellular matrix maintenance, are ongoing. Consistent nutritional support for those processes does not need to be adjusted based on cycle phase. It should be maintained throughout the training and competition season as a baseline from which the mare's soft tissue can manage whatever additional variables her hormonal cycle introduces.
Tendonall is formulated to support tendon and ligament biology and is used in management programs for performance mares as part of a sustained soft tissue strategy throughout the competition season.
The question of whether hormones affect soft tissue health in mares does not have a single definitive answer for the equine context. What it has is biological plausibility, consistent anecdotal support, and enough crossover from human sports medicine to take seriously as a management consideration. For owners and trainers responsible for performance mares through demanding seasons, that is enough to warrant attention and informed monitoring even without a complete evidence base.